Rationale Certifications for medical cannabis are generally restricted to a small number of
specific medical conditions, yet patients frequently report symptoms of pain, anxiety, and …

Global interest in the non‐intoxicating cannabis constituent, cannabidiol (CBD), is
increasing with claims of therapeutic effects across a diversity of health conditions. At …

Abstract Background In 2016, the Australian federal government passed legislation enabling
a range of cannabis-based products to be prescribed to patients by registered healthcare …

Background An increasing number of countries legalise the use of medical cannabis or
allow it for a narrow range of medical conditions. Physicians, and often the patients' general …

Background The number of jurisdictions allowing access to medicinal cannabis has been
steadily increasing since the state of California introduced legislation in 1996. Although …

SUMMARY The Australian Federal Government legalised access to medicinal cannabis in
2016. More than 100 different cannabis products are now available to prescribe. Most are …

Background: Medical cannabis has been legally available in Canada since 2001, but its
benefits and harms remain uncertain. We explored attitudes toward medical cannabis …

A regulatory framework allowing legal access to medicinal cannabis (MC) products has
operated in Australia since November 2016. MC prescribing by healthcare practitioners …

Due to the myriad of laws concerning cannabis, there is little empirical research regarding
the veterinary use of cannabidiol (CBD). This study gauged US veterinarians' knowledge …

In this review, the state of the art for compounds affecting the endocannabinoid (eCB)
system is described with a focus on the treatment of pain. Amongst directly acting CB …